Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
Yahoo! News
–
Results from hair growth products can vary in the time it takes to notice them. It’s best to address hair loss early — once about half of the hair in a particular area of the scalp is lost, patients tend to notice the problem.
Actress Danielle Fishel has been diagnosed with breast cancer, the Boy Meets World star revealed on her podcast. “I was recently diagnosed with DCIS, which stands for ductal carcinoma in situ, which is a form of breast cancer,” Fishel said. Fishel credits a reminder message for her early diagnosis. “The only reason I caught this cancer when it is still stage zero is because the day I got my text message that my yearly mammogram came up, I made the appointment,” she said. For the most part, doctors treat stage zero and stage 1 cancer the same way. The first step is almost invariably surgery, which Fishel says she plans to unergo. Some women choose to have a complete or partial mastectomy (also called a lupectomy) to remove all or part of the breast tissue. After surgery, if all the cancerous tissue has been removed, most patients will undergo radiation. If testing shows that their tumor is fueled by estrogen, patients may be put on an additional medication that suppresses the hormone and induces menopause. After that, “the vast majority of patients are cured, end of story,” William Gradishar, MD, chief of hematology and oncology and a professor of breast oncology at Northwestern University’s Feinberg School of Medicine explained. The survival rate for DCIS is 98%, according to the Breast Cancer Research Foundation.
-
Yahoo! News
–
The best hair growth products of 2024, according to dermatologists
Hair loss affects millions of people in the U.S., and the impacts go beyond physical appearance. Experiencing air loss can cause stress, lower self-esteem and depression because it’s a deeply personal aspect of body image and self-identity. Understanding why your hair is thinning or shedding is essential to finding the right solution for your hair loss. According to Amy Forman Taub, MD, FAAD, a board-certified dermatologist and assistant professor at Northwestern University Medical School, the most common cause of hair loss is androgenetic alopecia, aka male pattern hair loss or female pattern hair loss. “The second most common is called telogen effluvium and can be caused by many things, including severe stress, childbirth, certain drugs and thyroid abnormalities,” Taub says. Thankfully, in most cases, treating and reversing hair loss is successful with effective hair growth products. Results from hair growth products can vary in the time it takes to notice them. It’s best to address hair loss early — once about half of the hair in a particular area of the scalp is lost, patients tend to notice the problem.
-
CNN
–
Even before Matthew Perry’s death, experts worried about the ‘Wild West’ of ketamine treatment
Among five people charged in the death of actor Matthew Perry, two are doctors: According to federal officials, one agreed to sell ketamine from his former clinic and the other distributed the drug to Perry and taught his live-in-personal assistant how to inject it. Perry was injected multiple times the day of his death, the US Attorney’s Office for the Central District of California said, and an autopsy showed the amount of ketamine in his system had reached the level used for general anesthesia. Steven P. Cohen, MD, a professor of anesthesiology (pain medicine) at Northwestern University’s Feinberg School of Medicine, says some ketamine clinics are clearly putting profits before patients. Cohen said the clinics often don’t have a doctor evaluate patients. He’s heard of patients being given 35 to 40 milligrams of ketamine at a time, which may be subtherapeutic — in his experience, it takes about 400 milligrams given over a week effectively treat depression. He says clinics might not monitor patients’ progress, and they’re usually expected to pay cash for each treatment. “It’s disgusting. It’s the Wild West,” he said.
-
The New York Times
–
Many People Are Eligible for Paxlovid. Who Should Take It?
Most adults in the United States have one condition or another that makes them a candidate for Paxlovid, which can cut the risk of a severe case of Covid. Obesity, diabetes, depression, heart conditions and dozens of other issues all put people at high risk, according to the Centers for Disease Control and Prevention. More than two years after Paxlovid became widely available in the United States, and in the middle of yet another summer surge, patients and doctors are still frequently confused about who qualifies for the medication and exactly how beneficial it might be. It’s well-established that Paxlovid saves lives. But it can be costly, and it can interact with a lengthy list of medications. Some people avoid the drug, in part because they worry about experiencing a rebound case. One study found that only about 15 percent of people who were eligible for the medication took it when they had Covid. Your symptoms can come back after you recover from Covid, whether you took Paxlovid or not. While Pfizer researchers have estimated that just over 2 percent of people who take the drug experience rebound, outside estimates are closer to 14 percent. But the possibility of symptoms returning should not dissuade people from taking the medication, said Marc Sala, MD, a co-director of the Northwestern Medicine Comprehensive Covid-19 Center in Chicago.
-
New York Times
–
Late-Summer Travel Plans? You Might Want to Put On a Mask.
It is the height of the summer travel season: Airplanes and cruises are packed, hotels are booked, and travelers are crowding theme parks and attractions. Yet throughout the United States, Covid-19 is currently circulating at very high levels. During the peak of the pandemic, masks were ubiquitous in hotels, airports and other public places. They were required to fly, and many travelers donned them elsewhere to help reduce the transmission of the deadly coronavirus. Since the end of the mandate, and as travel has returned to or surpassed prepandemic levels, most travelers have abandoned preventive measures, particularly masks.“If you have symptoms and you have any question about it, I would wear a mask, just to protect other people,” said Marc Sala, MD, a co-director of the Northwestern Medicine Comprehensive Covid-19 Center in Chicago. Common symptoms of Covid include coughing, fever, sneezing, congestion, headaches, sore muscles, fatigue and gastrointestinal issues. Those who are asymptomatic but have been exposed to Covid may also consider masking. If you have tested positive during a trip but cannot delay traveling, you should wear a mask whenever you are around other people, Dr. Sala said.
-
Crain’s Chicago Business
–
Long COVID’s brain fog doesn’t lift for years
Neurological symptoms can linger even two or three years following a COVID-19 infection for more than 60% of those who contract the disease, scientists at Northwestern Medicine and the School of Medicine at CES University and the CES Clinic in Colombia have found. Their study found the symptoms of brain fog — cognitive dysfunction — was experienced by 60% of patients and fatigue was experienced by 74%. The two symptoms, along with depression, most affected long COVID patients whether their symptoms were severe or more mild, Northwestern said in a press release. In the longest COVID follow-up in Latin America, Igor J. Koralnik, chief of neuro-infectious diseases and global neurology at Northwestern University Feinberg School of Medicine, and Dr. Carolina Hurtado Montoya with the School of Medicine at CES University in Medellín, analyzed persistent neurological symptoms, cognitive function and quality of life in long COVID patients. The most common symptom of long COVID was fatigue, which 74 out of 100 patients experienced. Many long COVID patients also experienced muscle pain (42%), numbness or tingling (41%), sleep problems (46%) and anxiety (44%).
-
TODAY
–
Woman shocked when eye freckle turns into melanoma. This was her 1 symptom
Like many people with a freckle in the back of their eye, Debbie Hensley never knew she had one — until it potentially threatened her life. About 5% of Americans have a freckle in the back of their eye, known as a choroidal nevus, which is similar to a freckle or mole people have on their skin, according to the American Society of Retina Specialists. It’s not something a person can see, but is often picked up during a routine eye exam. These pigmented spots are usually harmless, says Christopher Bowen, MD, director of ocular oncology at Northwestern Medicine in Chicago, who treated Hensley. “I definitely want to emphasize that most of the time, having a freckle in the back of the eye is not a problem,” Bowen tells. “Only 1 in 8,000 people with freckles in the back of the eye undergo additional mutations that would then cause a melanoma.” Hensley was one of those rare cases. It’s unknown why some of these spots change from benign to cancerous, Bowen notes. Most people know melanoma as the deadliest form of skin cancer, but it can also start in the eye. The best way to monitor any eye freckles is to have regular dilated eye exams with a photo of the back of the eye, he adds.
-
Fox 32 Chicago
–
Chicago’s Lurie Children’s Hospital secures $12M to study antibiotic use in treating pediatric pneumonia
Antibiotic resistance is a growing concern in the U.S., particularly when it comes to treating pediatric pneumonia. Doctors are now questioning whether antibiotics should be used at all for this condition. Chicago’s Lurie Children’s Hospital, in collaboration with the University of Utah Health, has been awarded $12 million to investigate this issue. Their study will compare two methods of using antibiotics for treating pneumonia in children. “When you think about the millions of children that are diagnosed with pneumonia in the United States each year and the millions of days of antibiotics that those children receive, often times unnecessarily, you can see how the return on investment in the long run for children’s health is really in the positive,” said Todd Florin, MD, MSCE, associate professor at Northwestern University Feinberg School of Medicine. The research team will collaborate with 12 pediatric care offices to gather data over the next five years.
-
NBC News
–
NIH study to pinpoint long Covid diagnosis comes up short
Long Covid continues to evade a clear diagnostic test, researchers reported in a study published Monday in the Annals of Internal Medicine. The findings are part of the National Institute of Health’s RECOVER Initiative, a billion-dollar-plus effort launched in 2021 to research causes and treatments for the estimated 17 million Americans with long Covid. Patients in the study were determined to have long Covid based on a scoring system of 12 symptoms including brain fog, dizziness and palpitations, among others. Different symptoms were assigned different scores, and a long Covid diagnosis was met if the score reached a level of 12. Marc Sala, MD, a pulmonologist and co-director of the Comprehensive Covid Center at Northwestern Medicine, said the study was well done but noted that the results might be frustrating to the millions out there still suffering from the illness. “I think one of the criticisms that can be leveled against the study is that a lot of these labs that they sent are the same things that you get with your primary care doctor,” Sala said. “A lot of these tests weren’t exactly nuanced to looking for a novel reason for long Covid.” Sala said that while routine blood tests are often normal with his long Covid patients, more specialized testing — such as blood tests while a patient is exercising, or a CT scan after Covid pneumonia — turns up abnormal. He said patients, particularly those who are otherwise healthy and come in with an extraordinary amount of shortness of breath and fatigue, would need much more testing beyond what was done in the paper.
-
New York Times
–
Americans’ Struggle with Mental Health
It is no mystery why rates of anxiety and depression in the United States climbed in 2020, at the height of the pandemic. But then life began a slow return to normal. Why haven’t rates of distress returned to normal, too? Researchers say a big reason for this stubbornly elevated distress is young people, whose low mood was not linked to the pandemic. The share of young adults reporting anxiety and depression had been rising for about a decade before Covid struck. That continued throughout the pandemic — and did not ease as quickly when vaccines became available. This is likely because their symptoms were tied to problems other than the virus, like economic precarity, the housing crisis, social isolation and political turmoil, said Emma Adam, PhD, a psychologist at Northwestern. “There’s so many things affecting adolescents and young adults that are about uncertainty with their future,” Adam said. “And that hasn’t changed.” Age, of course, tracks with income. Adam’s team found that people between the ages of 18 and 39 were half as likely to live in their own home as their counterparts over 40. That means they were especially vulnerable to inflation, rent increases and job loss — just as they faced big decisions like whether to have children or own a home.
